{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:19:19Z","timestamp":1763356759030,"version":"3.45.0"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2025.1724208","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:16:37Z","timestamp":1763356597000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Cardiovascular comorbidities in inflammatory rheumatic diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Konstantinos","family":"Triantafyllias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Colina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durga Prasanna","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos","year":"2022","journal-title":"Ann Rheum Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/oso\/9780192868978.003.0003","article-title":"High cardiovascular risk in mixed connective tissue disease: evaluation of macrovascular involvement and its predictors by aortic pulse wave velocity","volume":"37","author":"Triantafyllias","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jjcc.2023.05.006","article-title":"Efficacy and safety of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan (RESCUE-2): a randomized, double-blind, placebo-controlled, phase 2 trial","volume":"82","author":"Wada","year":"2023","journal-title":"J Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.rdc.2022.07.004","article-title":"Atherosclerotic cardiovascular risk stratification in the rheumatic diseases:: an integrative, multiparametric approach","volume":"49","author":"Misra","year":"2023","journal-title":"Rheum Dis Clin North Am."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1093\/rheumatology\/kead584","article-title":"Increased mortality rate in Takayasu arteritis is largely driven by cardiovascular disease\u2014a cohort study","volume":"63","author":"Jagtap","year":"2024","journal-title":"Rheumatology (Oxford)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.3390\/diagnostics13243603","article-title":"Arterial stiffness as a surrogate marker of cardiovascular disease and atherosclerosis in patients with vasculitides: a literature review","volume":"13","author":"Triantafyllias","year":"2023","journal-title":"Diagnostics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13075-025-03625-5","article-title":"Oscillometric, greyscale- and novel color-Doppler-ultrasound indices of macrovascular damage in Sjogren's: the SICARD cohort study","volume":"27","author":"Triantafyllias","year":"2025","journal-title":"Arthritis Res Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"820263","DOI":"10.3389\/fmed.2022.820263","article-title":"Novel surrogate markers of cardiovascular risk in the setting of autoimmune rheumatic diseases: current data and implications for the future","volume":"9","author":"Mandel","year":"2022","journal-title":"Front Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s40744-024-00676-z","article-title":"cardiovascular risk evaluation in psoriatic arthritis by aortic stiffness and the systemic coronary risk evaluation (SCORE): results of the prospective PSOCARD cohort study","volume":"11","author":"Triantafyllias","year":"2024","journal-title":"Rheumatol Ther."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1724208\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:16:38Z","timestamp":1763356598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1724208\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":10,"alternative-id":["10.3389\/fmed.2025.1724208"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1724208","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"article-number":"1724208"}}